Adenocarcinomas
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Trial of Lenvatinib Plus PembrolizumAb in Recurrent Gynecological Clear Cell Adenocarcinomas (LARA) (NCT04699071) | National University Hospital, Singapore | 2021-02-18 |
| Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung Cancer (NCT03215810) | H. Lee Moffitt Cancer Center and Research Institute | 2017-10-11 |
Track Adenocarcinomas automatically
Every clearance here is in the API, with alerts when new ones post.